Santosh Vetticaden
Overview
Santosh Vetticaden received $951K in total compensation, including $151K in salary, at INSYS Therapeutics in 2017.
Source: SEC filing on April 16, 2018.
Related executives
We found seven more executives who work or worked at INSYS Therapeutics.
Saeed Motahari
INSYS Therapeutics
Chief Executive Officer
Franc Del Fosse
INSYS Therapeutics
General Counsel
Andrew Long
INSYS Therapeutics
Chief Financial Officer
Darryl Baker
INSYS Therapeutics
Chief Financial Officer
John Kapoor
INSYS Therapeutics
Chief Executive Officer
Daniel Brennan
INSYS Therapeutics
Chief Operating Officer
Michael Babich
INSYS Therapeutics